ZVRA
Zevra TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ZVRA vs peer average
80/100
ZVRA vs. peer average (A vs. C)
Grade spread
A 2 · B 2 · C 3 · D 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Same-sector, similar-market-cap candidate from the packet; peer fit is primarily size and biotech volatility rather than close indication overlap, so peer read-through should stay cautious.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ZVRA
Zevra Therapeutics
ACRS
Aclaris Therapeutics
Grade
A
A
Momentum
75
88
Value
41
41
Sentiment
70
68
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ACRS
ZVRA / ACRS
Grade Position
Above peers
ZVRA vs. peer average (A vs. C)
80/100
Momentum
75
ACRSValue
41
ZVRASentiment
70
ZVRARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ZVRA
ACRS is the first peer returned for this comparison set.